Introduction {#s1}
============

Down syndrome (DS) is the most common chromosomal disorder with the prevalence of 1/700--1000 live birth. It is characterized by the trisomy 21, which results from maternal meiotic nondisjunction in majority (90%) of cases. The established risk factor for DS is advanced (\>35 years) maternal age at the time of conception. However, a fairly high number of DS children born to younger mothers suggest that risk factors other than advanced maternal age might be involved in predisposing younger mothers to DS-affected pregnancy [@pone.0108552-Rai1], [@pone.0108552-Tayeb1]. The molecular and biochemical mechanism of maternal meiotic non-disjunction is still not known. James et al. [@pone.0108552-James1] reported that methylenetetrahydrofolate reductase (*MTHFR*) C677T polymorphism might be a risk factor for maternal meiotic non-disjunction. Since then several studies have investigated the risk of DS to variants of folate pathway genes like *MTHFR*, Methionine synthase (*MTR*) and Methionine synthase reductase (*MTRR*) in Asian [@pone.0108552-Rai1], [@pone.0108552-Tayeb1], [@pone.0108552-Wang1], [@pone.0108552-Kaur1] and Caucasian [@pone.0108552-Hobbs1]--[@pone.0108552-Boovi1] populations. Folate deficiency and dysfunctional MTHFR causes abnormal DNA methylation [@pone.0108552-James2], [@pone.0108552-Pogribny1] and chromosomal segregation [@pone.0108552-Pogribna1], [@pone.0108552-Parry1]. Hypomethylation of the centromeric DNA has been suggested as the causative mechanism of meiotic non-disjunction. Abnormal DNA methylation of centromere lead to aberrant kinetochore formation that results into abnormal segregation of chromosomes during meiosis [@pone.0108552-James1], [@pone.0108552-Pozzi1].

MTHFR is a key enzyme in folate metabolism, which catalyzes the reduction of 5, 10-methylenetetrahydrofolate to the predominant circulating form of folate i.e. 5-methyltetrahydrofolate (5-THF). 5-THF donates methyl group for the conversion of homocysteine to methionine, which is further converted into S-adenosylmethionine (SAM). SAM is the main methyl group donor for all cellular methylation reactions. Folate deficiency and/or dysfunctional MTHFR reduces the conversion of 5, 10-methylene THF to 5-methyl THF, and elevates plasma homocysteine concentration. Both folate and MTHFR are involved in many complex biochemical reactions like DNA synthesis, repair and methylation.

There are more than 40 polymorphisms reported in *MTHFR* gene and among them C677T variant is the most studied and clinically important. The C677T variant (rs 1801133; Ala 222 Val) has been associated with a decreased activity of MTHFR, and increased homocysteine level [@pone.0108552-Frosst1]--[@pone.0108552-Brattstrm1]. Mutant homozygous (TT) individuals have a decreased enzymatic activity ∼ 70% and the heterozygote by 40%. A dysfunctional MTHFR leads to lower levels of SAM resulting into DNA hypomethylation. DNA hypomethylation increases the risk of many diseases and disorders like- neural tube defects [@pone.0108552-vanderPut1], cleft lip and palate [@pone.0108552-Blanton1], Alzheimer disease [@pone.0108552-Hua1], cardiovascular diseases [@pone.0108552-Frosst1], diabetes [@pone.0108552-Benes1] and psychiatric disorders [@pone.0108552-Jnsson1] etc. Several epidemiological studies have investigated the associations of the maternal *MTHFR* C677T polymorphism with Down syndrome. However, the results were conflicting and inconclusive. In light of the above facts, we conducted a meta-analysis of published case control studies relating the C677T polymorphism of the maternal *MTHFR* gene to the risk of having DS offspring.

Materials and Methods {#s2}
=====================

Selection of studies {#s2a}
--------------------

Electronic searches were conducted using PubMed, Google Scholar, Elsevier and Springer link and all published manuscripts up to January, 2014 were considered in present meta-analysis. The following index terms were used for search '*MTHFR*' 'Methylenetetrahydrofolate reductase', and 'C677T polymorphism', 'maternal risk' and 'Down syndrome'. In addition, bibliographies of all articles and reviews were hand searched for additional suitable studies.

Inclusion criteria {#s2b}
------------------

Included studies had to meet the following criteria: (1) article should be published; (2) article should have sufficient data to calculate the odds ratio with 95% CI; (3) article should be case control association study; and (4) author should describe the genotyping protocols.

Data extraction {#s2c}
---------------

The following data were extracted from each study: first author's name, publication year, journal name, country name, genotyping method, and different *MTHFR* genotype numbers.

Meta-analysis {#s2d}
-------------

Statistical analysis of maternal *MTHFR* C677T polymorphism and DS risk was estimated by Odds ratio (ORs) with 95% confidence intervals (CIs). The heterogeneity was tested by the Q-statistics with p-values \<0.05. Subgroup analysis was done to know the source of heterogeneity. If higher heterogeneity (I^2^\>50%) would be observed, the random effect model [@pone.0108552-DerSimonian1] would be applied. Otherwise, fixed-effect model [@pone.0108552-Mantel1] was applied to obtain the summary OR and 95% CI. All p values were two-sided and a p value of less than 0.05 was considered statistically significant. All analyses were performed using the computer program MIX version 1.7 [@pone.0108552-Bax1]. The control genotypes were tested for Hardy-Weinberg equilibrium (HWE) using the Goodness of fit Chi-square test. The quality of the included studies was measured according to the scoring system for randomized controlled association studies proposed by Clark and Baudouin [@pone.0108552-Clark1]. Case control studies scoring \<5 were defined as low quality study and those ≥5 were defined as high quality study.

Publication bias {#s2e}
----------------

Funnel plots of precision by log (OR) and standard error by log (OR) were plotted to determine publication bias and asymmetrical funnel plots represent publication bias. Begg and Mazumdar rank correlation [@pone.0108552-Begg1] and Egger's regression intercept [@pone.0108552-Egger1] tests were adopted to assess the publication bias.

Results {#s3}
=======

Eligible Studies {#s3a}
----------------

With our original search criterion, 85 articles were found. After reviewing each original article, 50 publications were excluded including reviews, case studies, editorials etc. ([Figure 1](#pone-0108552-g001){ref-type="fig"}). Following these exclusions, 34 individual case-control studies with a total of 3,098 cases and 4,852 controls were found to be suitable for inclusion into meta-analysis and listed in [Table 1](#pone-0108552-t001){ref-type="table"} ([Figure 1](#pone-0108552-g001){ref-type="fig"}).

![Flow Diagram of Study Searching and Selection Process.](pone.0108552.g001){#pone-0108552-g001}

10.1371/journal.pone.0108552.t001

###### Characteristics of the eligible studies included in the meta-analysis.

![](pone.0108552.t001){#pone-0108552-t001-1}

  Study                       Year     Country      Case   Control   Quality Score                      Reference
  -------------------------- ------ -------------- ------ --------- --------------- -------------------------------------------------
  James et al.                1999      Canada       50      57            7                    Am J Clin Nutr 70∶495-50
  Hobbs et al.                2000     America      157      140           7                   Am J Hum Genet 67∶623--630
  Chadeaux-Vekemans et al.    2002      France       85      70            5                     Pediatr Res 51∶766--767
  O'Leary et al.              2002     Ireland       41      192           5                  Am J Med Genet A 107∶151--155
  Stuppia et al.              2002      Italy        64      112           7                   Eur J Hum Genet 10∶388--390
  Boduroglu et al.            2004      Turkey      158      91            5                   Am J Med Genet 127A: 5--10
  Acacio et al.               2005      Brazil       70      88            8                   Prenat Diagn 25∶1196--1199
  Da Silva et al.             2005      Brazil      154      158           7              Am J Med Genet Part A 135A: 263--267
  Coppede et al.              2006      Italey       79      111           7              Am J Med Genet A 140(10): 1083--1091
  Liang et al.                2006      China        30      70            7                 China J Modern Medicine 20∶011
  Rai et al.                  2006      India       149      165           6                     J Hum Genet 51∶278--283
  Scala et al.                2006      Italy        94      256           8                      Genet Med 8∶409--416
  Wang et al.                 2007      China       100      100           8         Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24∶533--537
  Biselli et al.              2008      Brazil       82      134           8                     Genet Mol Res 7∶33--42
  Kohli et al.                2008      India       103      109           6                Downs Syndr Res Pract 12∶133--137
  Martinez-Frias et al.       2008      Spain       146      188           4              Am J Med Genet A 146A(11): 1477--1482
  Meguid et al.               2008      Egypt        42      48            7                      Dis Markers 24∶19--26
  Santos-Reboucas et al.      2008      Brazil      103      108           7                     Dis Markers 25∶149--157
  Wang et al.                 2008      China        64      70            8               J Zhejiang Univ Sci B 9(2): 93--99
  Brandalize et al.           2009      Brazil      239      197           6              Am J Med Genet 149A (10): 2080--2087
  Coppede et al.              2009      Italy        94      113           8                    Neurosci Lett 449∶15--19
  Cyril et al.                2009      India        36      60            6                  Indian J Hum Genet 15∶60--64
  Kokotas et al.              2009     Denmark      177      984           6                     Dis Markers 27∶279--285
  Pozzi et al.                2009      Italy        74      184           8                 Am J Obstet Gynecol 63: e1--e6
  Coppede et al.              2010      Italy        29      32            5                      BMC Med Genomics 3∶42
  Liao et al.                 2010      China        60      68            7                    Yi Chuan 32(5): 461--466
  Vranekoviz et al.           2010     Croatia      111      141           7                     Dis Markers 28∶293--298
  Bozovic et al.              2011     Croatia      112      221           7                   Pediatr Int 53(4): 546--550
  Sadiq et al.                2012      Jordan       53      29            6                Genet Test Mol Biomarker 15∶1--7
  Tayeb                       2012   Saudi Arabia    30      40            5            Egyptian J Med Hum Genet 13(3): 263--268
  Zampieri et al.             2012      Brazil      105      185           8                    Dis Markers 32(2): 73--81
  Kaur and Kaur               2013      India       110      111           6               Indian J Hum Genet 19(4): 412--414
  Pandey et al.               2013      India        81      99            6              Int J Pharm Bio Sci; 4(2):(B)249--256
  Elsayed et al.              2014      Egypt        26      61            9           The Egyptian J Med Hum Genet 15(1): 39--44

These studies were published between 1999 and 2013. All these thirty four studies were performed in different countries- Brazil [@pone.0108552-Accio1]--[@pone.0108552-Zampieri1], China [@pone.0108552-Wang1], [@pone.0108552-Liang1]--[@pone.0108552-Liao1], Croatia [@pone.0108552-Boovi1], [@pone.0108552-Vranekovic1], Egypt [@pone.0108552-Meguid1], [@pone.0108552-Elsayed1], France [@pone.0108552-ChadefauxVekemans1], India [@pone.0108552-Rai1], [@pone.0108552-Kaur1], [@pone.0108552-Kohli1]--[@pone.0108552-Pandey1], Ireland [@pone.0108552-OLeary1], Italy [@pone.0108552-Scala1], [@pone.0108552-Pozzi1], [@pone.0108552-Stuppia1]--[@pone.0108552-Copped2], Jordan [@pone.0108552-Sadiq1], Netherlands [@pone.0108552-Kokotas1], Saudi Arabia [@pone.0108552-Tayeb1], Spain [@pone.0108552-MartnezFras1], Turkey [@pone.0108552-Bodurolu1] and USA [@pone.0108552-James1], [@pone.0108552-Hobbs1] ([Table 1](#pone-0108552-t001){ref-type="table"}).

Characteristics of included studies {#s3b}
-----------------------------------

In thirty four studies included in the present meta-analysis, the smallest case sample size was 26 [@pone.0108552-Elsayed1] and highest sample size was 239 [@pone.0108552-Brandalize1]. ORs for more than one were reported in twenty four articles [@pone.0108552-Rai1], [@pone.0108552-Tayeb1], [@pone.0108552-Wang1]--[@pone.0108552-Hobbs1], [@pone.0108552-Boovi1], [@pone.0108552-Pozzi1], [@pone.0108552-Accio1]--[@pone.0108552-Biselli1], [@pone.0108552-Brandalize1], [@pone.0108552-Zampieri1], [@pone.0108552-Wang2]--[@pone.0108552-Elsayed1], [@pone.0108552-Cyril1], [@pone.0108552-Pandey1], [@pone.0108552-Copped1]--[@pone.0108552-Sadiq1], [@pone.0108552-MartnezFras1], [@pone.0108552-Bodurolu1]. Except two studies [@pone.0108552-Accio1], [@pone.0108552-Pandey1], control populations of all articles were in Hardy-Weinberg equilibrium.

In all thirty four studies, total cases were 3,098 with CC (1,396), CT (1,326) and TT (376), and controls were 4,852 with CC (2,329), CT (2,015), and TT (508) genotypes. In controls genotypes, percentage of CC, CT and TT were 48.00%, 41.53%, and 10.47% respectively. In total cases, genotype percentage of CC, CT, and TT was 45.06%, 42.8% and 12.14% respectively. Frequencies of CC and CT genotypes were highest in both cases and controls ([Table 2](#pone-0108552-t002){ref-type="table"}). In cases and controls, the allele C was the most common. All five genetic models; -allele contrast (T vs C) homozygote (TT vs CC), codominant (CT vs CC), dominant (TT+CT vs CC) and recessive (TT vs CT+CC) models were used to evaluate C677T polymorphism as DS risk.

10.1371/journal.pone.0108552.t002

###### Distributions of MTHFR C677T genotypes and allele frequencies in DS case mothers and control mothers reported in different included studies.

![](pone.0108552.t002){#pone-0108552-t002-2}

                                                   CC   CT    TT     C    T                           
  -------------------------------- -------------- ---- ----- ----- ----- ---- ---- ----- ------ ----- -----
  James et al., 1999                   Canada      24   15    22    34    4    8    70     64    30    50
  Hobbs et al., 2000                  America      51   67    84    59    22   14   186   193    128   87
  Chadeaux-Vekemans et al., 2002       France      36   29    42    30    7    11   114    88    56    52
  O'Leary et al., 2002                Ireland      18   90    21    84    2    18   57    264    25    120
  Stuppia et al., 2002                 Italy       20   27    32    62    12   23   72    116    56    108
  Boduroglu et al., 2004               Turkey      86   58    55    30    17   3    227   146    89    36
  Acacio et al., 2005                  Brazil      35   54    30    25    5    9    100   133    40    43
  Da Silva et al., 2005                Brazil      67   84    72    67    15   7    206   235    102   81
  Coppede et al., 2006                 Italey      20   39    43    54    16   18   83    132    75    90
  Liang et al., 2006                   China       7    16    20    34    3    20   34     66    26    74
  Rai et al., 2006                     India       97   124   40    39    12   2    234   287    64    43
  Scala et al., 2006                   Italy       31   74    39    125   24   57   101   273    87    239
  Wang et al., 2007                    China       28   48    52    42    20   10   108   138    92    62
  Biselli et al., 2008                 Brazil      29   100   35    77    8    17   93    229    71    39
  Kohli et al., 2008                   India       74   71    29    32    0    6    177   174    29    44
  Martinez-Frias et al., 2008          Spain       61   76    61    85    24   27   183   237    109   139
  Meguid et al., 2008                  Egypt       20   33    17    12    5    3    57     78    27    18
  Santos-Reboucas et al., 2008         Brazil      51   49    43    47    9    12   145   145    61    71
  Wang et al., 2008                    China       14   36    32    29    18   5    60    101    68    39
  Brandalize et al., 2009              Brazil      94   86    113   93    32   18   301   265    177   129
  Coppede et al., 2009                 Italy       25   40    52    55    17   18   102   135    86    91
  Cyril et al., 2009                   India       33   60     3     0    0    0    69    120     3     0
  Kokotas et al., 2009                Denmark      92   445   72    449   13   90   256   1339   98    629
  Pozzi et al., 2009                   Italy       28   62    30    93    16   29   86    217    62    151
  Coppede et al., 2010                 Italy       5    11    19    17    5    4    29     39    29    25
  Liao et al., 2010                    China       12   23    26    33    22   12   50     79    70    57
  Vranekoviz et al., 2010             Croatia      49   66    49    64    13   11   147   196    75    86
  Bozovic et al., 2011                Croatia      46   101   55    97    11   23   147   299    77    143
  Sadiq et al., 2011                   Jordan      23   23    27     5    3    1    73     51    33     7
  Tayeb, 2012                       Saudi Arabia   16   22    10    14    4    4    42     58    18    22
  Zampieri et al., 2012                Brazil      40   94    55    73    10   18   135   261    75    109
  Kaur & Kaur, 2013                    India       86   89    22    22    2    0    194   200    26    22
  Pandey et al., 2013                  India       67   87    12     9    2    3    146   183    16    15
  Elsayed et al., 2014                 Egypt       11   30    12    24    3    7    34     84    18    38

Meta-analysis {#s3c}
-------------

Meta-analysis with allele contrast showed significant association between maternal 677T allele and DS with both fixed effect (OR~TvsC~ = 1.22; 95% CI = 1.13--1.31; p = \<0.0001) and random effect models (OR~TvsC~ = 1.26; 95% CI = 1.09--1.45; p = 0.001) ([Figure 2](#pone-0108552-g002){ref-type="fig"}) ([Table 3](#pone-0108552-t003){ref-type="table"}). In cumulative meta-analysis using random effect model, the association of maternal T allele with DS turned statistically significant with the addition of study of Wang et al. (2008) and remained significant thereafter.

![Forest plots (Random effect) showed significant association between MTHFR C677T polymorphism and risk of Down syndrome using allele contrast model (C versus T).\
Results of individual and summary OR estimates and 95% CI of each study were shown. Horizontal lines represented 95% CI, and dotted vertical lines represent the value of the summary OR.](pone.0108552.g002){#pone-0108552-g002}

10.1371/journal.pone.0108552.t003

###### Summary estimates for the odds ratio (OR) of MTHFR C677T in various allele/genotype contrasts, the significance level (p value) of heterogeneity test (Q test), the I^2^ metric and publication bias p-value (Egger Test) in total studies, Asian, American and European studies.

![](pone.0108552.t003){#pone-0108552-t003-3}

  GeneticContrast                                Fixed effect OR(95% CI), p   Random effect OR(95% CI), p   Heterogeneityp-value (Q test)   I^2^ (%)   Publication Bias(p of Egger's test)
  ----------------- --------------------------- ---------------------------- ----------------------------- ------------------------------- ---------- -------------------------------------
  All                Allele Contrast (T vs. C)   1.22 (1.13−1.31), \<0.0001     1.26 (1.09−1.46), 0.001               \<0.0001               69.42                    0.14
                      Co-dominant (CT vs. CC)    1.23 (1.11−1.36), \<0.0001     1.29 (1.10−1.51), 0.001                0.0002                52.49                    0.02
                      Homozygote (TT vs. CC)     1.44 (1.22−1.69), \<0.0001     1.49 (1.13−1.97), 0.008               \<0.0001                57.3                    0.56
                      Dominant (TT+CT vs. CC)    1.28 (1.16−1.41), \<0.0001    1.35 (1.13−1.60), 0.0008               \<0.0001               63.56                    0.05
                     Recessive (CT+CC vs. TT)     0.76 (0.65−0.88), 0.0004      0.76 (0.60−0.94), 0.01                 0.0044                43.68                    0.926
  Asian              Allele Contrast (T vs. C)   1.53 (1.29−1.82), \<0.0001      1.52 (1.09−2.1), 0.01                 0.0003                69.43                    0.82
                      Co-dominant (CT vs. CC)     1.52 (1.21−1.91), 0.0003      1.57 (1.14−2.14), 0.005                 0.09                 38.05                    0.11
                      Homozygote (TT vs. CC)     2.41 (1.62−3.59), \<0.0001    2.21 (1.03−4.74), 0.0411                0.0074                60.04                    0.204
                      Dominant (TT+CT vs. CC)    1.64 (1.32−2.0), \<0.0001      1.70 (1.18−2.4), 0.004                  0.01                 56.67                    0.30
                     Recessive (CT+CC vs. TT)    0.54 (0.37−0.78), \<0.0001     0.58 (0.29−1.16), 0.12                 0.0094                58.77                    0.334
  American           Allele Contrast (T vs. C)    1.23 (1.07−1.39), 0.003       1.19 (0.99−1.44), 0.06                  0.06                 47.69                    0.11
                      Co-dominant (CT vs. CC)     1.42 (1.17−1.71), 0.0002      1.42 (0.97−2.06), 0.066                0.0005                73.15                    0.908
                      Homozygote (TT vs. CC)      1.68 (1.24−2.28), 0.0008      1.58 (0.84−2.95), 0.148                0.0007                72.07                    0.667
                      Dominant (TT+CT vs. CC)    1.48 (1.24−1.76), \<0.0001     1.44 (0.95−2.19), 0.078               \<0.0001               80.11                    0.782
                     Recessive (CT+CC vs. TT)     0.69 (0.51−0.92), 0.0136      0.72 (0.44−1.18), 0.203                0.0159                59.42                    0.753
  European           Allele Contrast (T vs. C)    1.03 (0.93−1.15), 0.482       1.04 (0.93−1.16), 0.451                0.3576                 8.81                    0.084
                      Co-dominant (CT vs. CC)     0.99 (0.85−1.16), 0.956       1.00 (0.85−1.17), 0.992                0.3774                 6.87                    0.050
                      Homozygote (TT vs. CC)      1.09 (0.87−1.37), 0.422       1.09 (0.85−1.40), 0.455                0.3715                 7.45                    0.329
                      Dominant (TT+CT vs. CC)     1.02 (0.88−1.17), 0.787       1.03 (0.87−1.21), 0.704                 0.308                13.58                    0.041
                     Recessive (CT+CC vs. TT)     0.90 (0.73−1.10), 0.322       0.90 (0.72−1.11), 0.339                 0.570                  0                      0.948

[Table 3](#pone-0108552-t003){ref-type="table"} summarizes the ORs with corresponding 95% CIs for association between maternal C677T polymorphism and risk of DS in dominant, recessive, homozygote and co-dominant models. With our primary analysis, there was an increased risk of DS among mutant homozygote variants (TT), with both fixed (OR~TTvs.CC~ = 1.44; 95% CI = 1.22−1.69, p = \<0.0001) and random (OR~TTvs.CC~ = 1.49; 95% CI = 1.13−1.97, p = 0.008) effect models with moderate statistical heterogeneity between-study ([Figure 3](#pone-0108552-g003){ref-type="fig"}). Association of mutant heterozygous genotype (CT vs. CC) was observed significant with fixed (OR~CTvs.CC~ = 1.23; 95% CI = 1.11−1.36; p = \<0.0001) and random (OR~CTvs.CC~ = 1.29; 95% CI = 1.10−1.51; p = 0.001) effect models. Similarly combined mutant genotypes (TT+CT vs. CC) showed significant association with DS using both fixed (OR~TT+CTvs.CC~ = 1.28; 95% CI = 1.16−1.41; p = \<0.0001) and random (OR~TT+CTvs.CC~ = 1.35; 95% CI = 1.13−1.60; p = 0.0008) effect models ([Figure 4](#pone-0108552-g004){ref-type="fig"}).

![Forest plots (Random effect) showed significant association between MTHFR C677T polymorphism and risk of Down syndrome.\
Results of individual and summary OR estimates and 95% CI of each study were shown using homozygote model (TT versus CC).](pone.0108552.g003){#pone-0108552-g003}

![Forest plots (Random effect) showed significant association between MTHFR C677T polymorphism and risk of Down syndrome using dominant model (TT+CT versus CC).\
Results of individual and summary OR estimates and 95% CI of each study were shown.](pone.0108552.g004){#pone-0108552-g004}

Stratified analysis {#s3d}
-------------------

We also performed sub-group analysis which is based on geographic distribution of population. Out of 34 studies included in present meta-analysis, 11 studies were from Asia, 13 from Europe, 8 from America and 2 from Africa. The subgroup analysis by geographical regions revealed that the significant association between the maternal *MTHFR* C677T polymorphism and DS existed in Asian population (for T vs. C: OR = 1.51; 95% CI = 1.09−2.10; p = 0.01; I^2^ = 69.43%; P~heterogeneity~ = 0.0003; P~Pb~ = 0.82) ([Figure 5](#pone-0108552-g005){ref-type="fig"}; [Table 3](#pone-0108552-t003){ref-type="table"}). Except allele contrast model of American population (T vs. C: OR = 1.23; 95% CI = 1.07−1.39; p = 0.003; I^2^ = 47.69%; P~heterogeneity~ = 0.06; P~Pb~ = 0.11) ([Figure 6](#pone-0108552-g006){ref-type="fig"}) no significant association was found in American and European population (for T vs. C: OR = 1.03; 95% CI = 0.93−1.15; p = 0.482; I^2^ = 8.81%; P~heterogeneity~ = 0.357; P~Pb~ = 0.084) ([Figures 7](#pone-0108552-g007){ref-type="fig"}; [Table 3](#pone-0108552-t003){ref-type="table"}).

![Forest plots (Random effect) showed significant association between MTHFR C677T polymorphism and risk of Down syndrome in Asian studies using allele contrast model (T versus C).\
Results of individual and summary OR estimates and 95% CI of each study were shown.](pone.0108552.g005){#pone-0108552-g005}

![Forest plots (Random effect) showed no association between MTHFR C677T polymorphism and risk of Down syndrome in American studies using allele contrast model (T versus C).\
Results of individual and summary OR estimates and 95% CI of each study were shown.](pone.0108552.g006){#pone-0108552-g006}

![Forest plots (Fixed effect) showed no association between MTHFR C677T polymorphism and risk of Down syndrome in European studies using allele contrast model (T versus C).\
Results of individual and summary OR estimates and 95% CI of each study were shown. Horizontal lines represented 95% CI, and dotted vertical lines represent the value of the summary OR.](pone.0108552.g007){#pone-0108552-g007}

Heterogeneity and Sensitive analysis {#s3e}
------------------------------------

A true heterogeneity existed between studies for allele (P~heterogeneity~ = \<0.0001, Q = 107.92, df = 33, I^2^ = 69.42%, t^2^ = 0.12) and mutant genotypes (P~heterogeneity~ = \<0.0001, Q = 74.90, df = 32, I^2^ = 57.3%, t^2^ = 0.10) comparisons. The 'I^2^' value of more than 50% for between studies comparison in both allele and genotype analysis shows high level of true heterogeneity. In Asian (P~heterogeneity~ = 0.0003, I^2^ = 67.43%) and American (P~heterogeneity~ = \<0.0001, I^2^ = 83.25%) allele contrast meta-analysis significant high heterogeneity was observed, in European sub-group meta-analysis low heterogeneity was observed (P~heterogeneity~ = 0.357, I^2^ = 8.81) in allele contrast model.

In allele contrast meta-analysis, sensitivity analysis performed by exclusion of the studies in which control population was not in Hardy Weinberg equilibrium, studies with small sample size and studies with high p values. Control population of only two studies [@pone.0108552-Accio1], [@pone.0108552-Pandey1] were not in HW equilibrium and heterogeneity did not decreased after exclusion of these studies (p = \<0.0001, I^2^ = 70.00%). Exclusion of seven studies with small sample size, less than 50 (O'Leary et al. [@pone.0108552-OLeary1], n = 41; Liang et al. [@pone.0108552-Liang1], n = 30; Mequid et al [@pone.0108552-Meguid1], n = 42; Cyril et al. [@pone.0108552-Cyril1], n = 36; Coppede et al. [@pone.0108552-Copped2], n = 29; Tayeb [@pone.0108552-Tayeb1], n = 30; Elsayed et al. [@pone.0108552-Elsayed1], n = 26), also did not decreased heterogeneity (P~heterogeneity~ = \<0.0001, I^2^ = 72.98%). Similarly exclusion of eleven studies with very high p value (O'Leary et al. [@pone.0108552-OLeary1], p = 0.87; Acacio et al. [@pone.0108552-Accio1], p = 0.40; Scala et al. [@pone.0108552-Scala1], p = 0.91; Martinez-Frias et al. [@pone.0108552-MartnezFras1], p = 0.90; Pozzi et al. [@pone.0108552-Pozzi1], p = 0.84;Vranekoviz et al. [@pone.0108552-Vranekovic1], p = 0.43; Bozovic et al. [@pone.0108552-Boovi1], p = 0.58; Tayeb [@pone.0108552-Tayeb1], p = 0.74; Elsayed et al. [@pone.0108552-Elsayed1], p = 0.65; Kaur and Kaur [@pone.0108552-Kaur1], p = 0.52; Pandey et al. [@pone.0108552-Pandey1], p = 0.44) did not decrease heterogeneity but increased odds ratio (OR = 1.29, 95% CI = 1.18−1.41, p = \<0.0001).

Publication bias {#s3f}
----------------

Publication bias was not observed in allele contrast, homozygote, dominant and recessive models (Begg's p = 0.28, Egger's p = 0.14 for T vs. C; Begg's p = 0.38, Egger's p = 0.56 for TT vs. CC; Begg's p = 0.13, Egger's p = 0.05 for TT+CT vs. CC and Begg's p = 0.19, Egger's p = 0.0.05 for TT vs. CC+CT) but publication bias was observed in co-dominant model (Begg's p = 0.04, Egger's p = 0.02 for CT vs. CC) of overall by using Begg's and Egger's test ([Table 3](#pone-0108552-t003){ref-type="table"}). Funnel plots were showed in [Figures 8](#pone-0108552-g008){ref-type="fig"} and [9](#pone-0108552-g009){ref-type="fig"}.

![Funnel plots a−f. a.\
Precision by log odds ratio for additive model; **b.** standard error by log odds ratio for additive model; **c.** precision by log odds ratio for co-dominant model; **d.** standard error by log odds ratio for co-dominant model; **e.** precision by log odds ratio for dominant model; **f.** standard error by log odds ratio for Dominant model.](pone.0108552.g008){#pone-0108552-g008}

![Funnel plots a−f. a.\
Precision by log odds ratio for additive model; **b.** standard error by log odds ratio for additive model for Asian studies; **c.** precision by log odds ratio for additive model; **d.** standard error by log odds ratio for additive model for American studies; **e.** precision by log odds ratio for additive model; **f.** standard error by log odds ratio for additive model for European studies.](pone.0108552.g009){#pone-0108552-g009}

Discussion {#s4}
==========

In 1999, James et al [@pone.0108552-James1] reported that genetic polymorphism of folate and homocysteine pathway enzymes predispose a woman to abnormal chromosome segregation, which act as risk factor for DS pregnancy. In subsequent years, several in vivo studies in humans suggested that chronic folate deficiency has been associated with abnormal DNA methylation [@pone.0108552-Pogribna1], [@pone.0108552-Balaghi1], [@pone.0108552-Fenech1], and aberrant chromosome segregation [@pone.0108552-Hobbs1], . Population-based studies have shown that folic acid intake during fetal development has a protective effect, resulting in a significant reduction in the occurrence of developmental defects, like neural tube defects (NTD), congenital heart defects, limb defects, and orofacial clefts [@pone.0108552-Botto1].

Meta-analysis is a powerful tool for analyzing cumulative data with small and low power studies. Several meta-analyses were published accessing *MTHFR* as risk factor to various diseases/disorders like- neural tube defects [@pone.0108552-Zhang1], [@pone.0108552-Yadav1], cleft lip and palate [@pone.0108552-Zhao1], stroke [@pone.0108552-Yadav2], psychiatric disorders [@pone.0108552-Peerbooms1]. During literature search, we identified four meta-analyses [@pone.0108552-Zintzaras1]--[@pone.0108552-Yang1] published between 2007 and 2013. They examined the effect of maternal *MTHFR* C677T as DS risk, but no consistent conclusion was achieved. Zintzaras [@pone.0108552-Zintzaras1] performed a meta-analysis based on eleven studies and did not find any significant association between the maternal *MTHFR* polymorphisms and DS risk. Medica et al. [@pone.0108552-Medica1] aggregated sixteen studies and reported significant relationship between the maternal mutant genotypes (TT+CT vs CC) and risk of DS child. Recently, Wu et al. [@pone.0108552-Wu1] published a meta-analysis (included twenty eight studies with 2806 cases/4597 controls), and found statistical association with dominant model (OR = 1.305, 95% CI = 1.125--1.514, p = 0, p = 0.003). Yang et al. [@pone.0108552-Yang1] performed a meta-analysis which was based on twenty six studies (2458 cases/3144 controls) and found statistically significant association in allele contrast model (OR = 1.28; 95% CI: 1.11--1.47) ([Table 4](#pone-0108552-t004){ref-type="table"}). Several newly published studies were not included in the previous published meta-analyses. So authors conducted a comprehensive meta-analysis with the largest number of studies (34 studies). In the present meta-analysis significant association was found between maternal C677T polymorphism and DS risk in total 34 studies using all five genetic models. Whereas in stratified analysis, except allele contrast model in American population, no significant association was observed in European and American population but significant higher risk was found in Asian population. Such phenomenon probably could be ascribed to the folate metabolism profile and dietary structure of different regions.

10.1371/journal.pone.0108552.t004

###### A comparative analysis of details of Odds Ratio, 95% CI, genetic models reported in total 5 (including present) meta-analysis published so far analyzing case-control studies of *MTHFR* C677T polymorphism and Down syndrome.

![](pone.0108552.t004){#pone-0108552-t004-4}

  Study                  Number of Studies   Cases   Controls   I^2^ (%)   Heterogeneity p-value (Q test)      OR (95% CI), p-value           Model         Subgroup analysis
  --------------------- ------------------- ------- ---------- ---------- -------------------------------- ---------------------------- ------------------ -------------------
  Zintaras, 2007                11           1129      1489        49                   0.03                    1.20 (1.06--1.35)        Allelic contrast     Not reported
  Medica et al., 2009           16           1545      2052        --                    --                 1.40 (1.16--1.70), 0.0006     Dominant model      Not reported
  Yang et al., 2013             26           2458      3144       58.2                 \<0.01                   1.28 (1.11--1.47)        Allelic contrast       Reported
  Wu et al., 2013               28           2806      4597       48.0                  0.0                 1.224 (1.085--1.38), 0.001    Dominant model        Reported
  Present Study, 2014           34           3048      4852      69.42                \<0.0001               1.26 (1.09--1.46), 0.001    Allelic contrast       Reported

There are few limitations of the present meta-analysis like- i) we used crude ORs in the pooled analysis without adjustment; ii) the relatively small sample size in some of the included studies, especially those from Asia; iii) we considered only one gene polymorphism (*MTHFR* C677T) of folate pathway. Present meta-analysis had several advantages/strength to the previous published meta-analyses like- (i) the publication bias was not detected in present meta-analysis, (ii) pooled number of cases and controls from different studies significantly increased the statistical power of the analysis, (iii) largest number of studies (34 studies) with largest sample size (3,098 cases and 4,852 controls) was included in the present meta-analysis, (iv) controls included in the present meta-analysis was mothers of healthy child, (v) distribution of genotypes in control mothers except two studies was in Hardy-Weinberg equilibrium, (vi) significant association was found between maternal *MTHFR* C677T polymorphism and DS risk in allelic contrast, homozygote, co-dominant and dominant genetic models and (vii) in addition we did sub-group analysis according to geographical regions.

In conclusion, results of present meta-analysis suggest that the maternal *MTHFR* 677T allele is a risk factor for development of DS pregnancy. However the results of present meta-analysis were based on single gene polymorphism and significant heterogeneity was also observed; hence results should be interpreted with caution.
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